- Home
- CGEM vs TRC Comparison
CGEM vs TRC Comparison
Compare CGEM & TRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- TRC
- Stock Information
- Founded
- CGEM 2016
- TRC 1843
- Country
- CGEM United States
- TRC United States
- Employees
- CGEM N/A
- TRC N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- TRC Real Estate
- Sector
- CGEM Health Care
- TRC Finance
- Exchange
- CGEM Nasdaq
- TRC Nasdaq
- Market Cap
- CGEM 437.2M
- TRC 419.0M
- IPO Year
- CGEM 2021
- TRC N/A
- Fundamental
- Price
- CGEM $8.53
- TRC $15.92
- Analyst Decision
- CGEM Strong Buy
- TRC
- Analyst Count
- CGEM 7
- TRC 0
- Target Price
- CGEM $26.00
- TRC N/A
- AVG Volume (30 Days)
- CGEM 793.3K
- TRC 85.4K
- Earning Date
- CGEM 11-06-2025
- TRC 11-06-2025
- Dividend Yield
- CGEM N/A
- TRC N/A
- EPS Growth
- CGEM N/A
- TRC N/A
- EPS
- CGEM N/A
- TRC 0.11
- Revenue
- CGEM N/A
- TRC $46,420,000.00
- Revenue This Year
- CGEM N/A
- TRC N/A
- Revenue Next Year
- CGEM N/A
- TRC N/A
- P/E Ratio
- CGEM N/A
- TRC $145.07
- Revenue Growth
- CGEM N/A
- TRC 15.71
- 52 Week Low
- CGEM $5.68
- TRC $14.71
- 52 Week High
- CGEM $14.15
- TRC $19.39
- Technical
- Relative Strength Index (RSI)
- CGEM 58.64
- TRC 47.03
- Support Level
- CGEM $7.93
- TRC $16.09
- Resistance Level
- CGEM $9.10
- TRC $16.51
- Average True Range (ATR)
- CGEM 0.66
- TRC 0.38
- MACD
- CGEM 0.07
- TRC 0.04
- Stochastic Oscillator
- CGEM 77.20
- TRC 45.34
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely Real Estate - Commercial/Industrial, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.